Artwork

Contenuto fornito da Stock Day Media. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Stock Day Media o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Skinvisible Inc. | SFWJ DBA MedCana

0:54
 
Condividi
 

Manage episode 416992991 series 180440
Contenuto fornito da Stock Day Media. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Stock Day Media o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Skinvisible, Inc. (OTCQB:SKVI) is excited to share a promising update on the ongoing clinical trials conducted by its licensee, Quoin Pharmaceuticals, Inc. (NASDAQ:QNRX). The trials focus on the innovative formulation “QRX003,” powered by Skinvisible’s Invisicare® proprietary drug delivery technology, to address the challenges of Netherton Syndrome (“NS”).
SFWJ DBA MedCana announces that Eko2o S.A.S, a Majority Controlled subsidiary of MedCana/SWJ in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, proudly announces a significant partnership with Danziger Colombia. This strategic agreement, expected to generate between $2.5 million and $3 million in revenue over the next three years, marks a pivotal moment for both organizations in their commitment to innovative agricultural practices.
Eko2o will be providing greenhouse infrastructure services, irrigation products and technology as well as other technologies related to Danziger’s flower operations in Colombia.
For more information, visit StockDayMedia.com
  continue reading

1487 episodi

Artwork

Skinvisible Inc. | SFWJ DBA MedCana

Stock Day Media

61 subscribers

published

iconCondividi
 
Manage episode 416992991 series 180440
Contenuto fornito da Stock Day Media. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Stock Day Media o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Skinvisible, Inc. (OTCQB:SKVI) is excited to share a promising update on the ongoing clinical trials conducted by its licensee, Quoin Pharmaceuticals, Inc. (NASDAQ:QNRX). The trials focus on the innovative formulation “QRX003,” powered by Skinvisible’s Invisicare® proprietary drug delivery technology, to address the challenges of Netherton Syndrome (“NS”).
SFWJ DBA MedCana announces that Eko2o S.A.S, a Majority Controlled subsidiary of MedCana/SWJ in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, proudly announces a significant partnership with Danziger Colombia. This strategic agreement, expected to generate between $2.5 million and $3 million in revenue over the next three years, marks a pivotal moment for both organizations in their commitment to innovative agricultural practices.
Eko2o will be providing greenhouse infrastructure services, irrigation products and technology as well as other technologies related to Danziger’s flower operations in Colombia.
For more information, visit StockDayMedia.com
  continue reading

1487 episodi

Alle Folgen

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida